Symbol: |
VTI1B
|
Description: |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) [Source:HGNC Symbol;Acc:17793]
|
Location: |
Chr14:68113792-68141548[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:150
Gene |
Compound |
Gen_sig |
Exp_pattern |
VTI1B |
Herveline O |
0.045 |
Up |
VTI1B |
NSC 676780 |
0.008 |
Up |
VTI1B |
NSC 676789 |
0.001 |
Up |
VTI1B |
NSC 677810 |
0.037 |
Down |
VTI1B |
16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol |
0.011 |
Up |
VTI1B |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.035 |
Up |
VTI1B |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.015 |
Down |
VTI1B |
5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) |
0.039 |
Up |
VTI1B |
NSC 681776 |
0.029 |
Down |
VTI1B |
NSC 682007 |
0.048 |
Up |
VTI1B |
NSC 684807 |
0.008 |
Up |
VTI1B |
2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 |
0.023 |
Down |
VTI1B |
NSC 685285 |
0.003 |
Up |
VTI1B |
NSC 685827 |
0.014 |
Up |
VTI1B |
4(3H)-Quinazolinone, 3-[[(2-nitrophenyl)methylene]amino]-2-phenyl- |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:6
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev]  Next Last 
|